(Q34583730)

3 August 2017

1 reference

title

Gastrointestinal manifestations of systemic sclerosis. (English)

1 reference

3 August 2017

Robyn Domsic

1

1 reference

3 August 2017

Kenneth Fasanella

series ordinal

2

1 reference

3 August 2017

Klaus Bielefeldt

series ordinal

3

1 reference

3 August 2017

13 October 2007

1 reference

Digestive Diseases and Sciences

3 August 2017

1 reference

3 August 2017

53

1 reference

3 August 2017

5

1 reference

3 August 2017

1163-1174

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-007-0018-8

3 August 2017

0 references

cites work

Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis

2 references

https://api.crossref.org/works/10.1007%2FS10620-007-0018-8

21 January 2018

12 December 2020

Gastroesophageal Reflux in Esophageal Scleroderma: Diagnosis and Implications

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0018-8

Pulmonary function and gastroesophageal reflux in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0018-8

Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-007-0018-8

Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response

21 January 2018

1 reference

12 December 2020

A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

1 reference

12 December 2020

Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence

1 reference

12 December 2020

Fecal incontinence in scleroderma. Clinical features, anorectal manometric findings, and their therapeutic implications.

1 reference

12 December 2020

Interdigestive motor activity in patients with systemic sclerosis

1 reference

12 December 2020

Esophageal involvement and pulmonary manifestations in systemic sclerosis

1 reference

12 December 2020

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial

1 reference

12 December 2020

Diabetic gastropathy and prokinetics

1 reference

12 December 2020

Is scleroderma an autoantibody mediated disease?

1 reference

12 December 2020

Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids

1 reference

12 December 2020

Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence

1 reference

12 December 2020

Oesophageal acid clearance in patients with systemic sclerosis: effect of body position

1 reference

12 December 2020

Effects of cisapride on colonic transit in patients with progressive systemic sclerosis

1 reference

12 December 2020

Prevalence of scleroderma spectrum disorders in the general population of South Carolina

1 reference

12 December 2020

Gastrointestinal motility disorders in scleroderma

1 reference

12 December 2020

Systemic sclerosis mortality in the United States: 1979-1998.

1 reference

12 December 2020

Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients.

1 reference

12 December 2020

The "hide-bound" bowel sign

1 reference

12 December 2020

Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis

1 reference

12 December 2020

Myenteric neuronal antibodies in scleroderma: passive transfer evokes alterations in intestinal myoelectric activity in a rat model.

1 reference

12 December 2020

Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term

1 reference

12 December 2020

Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults

1 reference

12 December 2020

Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: ultrastructural study of 3 cases

1 reference

12 December 2020

Gastrointestinal manifestations in Hungarian scleroderma patients

1 reference

12 December 2020

Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis

1 reference

12 December 2020

Mechanisms and consequences of fibrosis in systemic sclerosis

1 reference

12 December 2020

Antireflux operations in patients with scleroderma

1 reference

12 December 2020

Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome

1 reference

12 December 2020

Sacral nerve stimulation for faecal incontinence due to systemic sclerosis

1 reference

12 December 2020

Esophageal manometry in systemic sclerosis: screening procedure or confined to symptomatic patients?

1 reference

12 December 2020

Perineural and intraneural inflammatory infiltrates in the intestines of patients with systemic connective-tissue disease

1 reference

12 December 2020

Scleroderma and related disorders: therapeutic aspects

1 reference

12 December 2020

Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux.

1 reference

12 December 2020

Comparative esophageal and anorectal motility in scleroderma

1 reference

12 December 2020

Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction

1 reference

12 December 2020

Gastric involvement in systemic sclerosis: a prospective study.

1 reference

12 December 2020

Prevalence of Barrett's esophagus in systemic sclerosis

1 reference

12 December 2020

Lactobacillus sepsis associated with probiotic therapy.

1 reference

12 December 2020

Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography.

1 reference

12 December 2020

Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities

1 reference

12 December 2020

Esophageal hypomotility in systemic sclerosis: close relationship with pulmonary involvement

1 reference

12 December 2020

Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications

1 reference

12 December 2020

Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis

1 reference

12 December 2020

Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary?

1 reference

12 December 2020

Pneumatosis cystoides intestinalis in progressive systemic sclerosis: a case report and literature review

1 reference

12 December 2020

Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity

1 reference

12 December 2020

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

1 reference

12 December 2020

1988: Surgery for scleroderma of the esophagus: a 12-year experience. Updated in 1995

1 reference

12 December 2020

Metoclopramide response in patients with early diffuse systemic sclerosis. Effects on esophageal motility abnormalities.

1 reference

12 December 2020

Esophageal disease in scleroderma

1 reference

12 December 2020

Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis

1 reference

12 December 2020

High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride

1 reference

12 December 2020

Prokinetic therapy: what can be measured by gastric scintigraphy?

1 reference

12 December 2020

Review article: current therapeutic options for gastric antral vascular ectasia

1 reference

12 December 2020

Effect of progressive systemic sclerosis on antral myoelectrical activity and gastric emptying.

1 reference

12 December 2020

Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders.

1 reference

12 December 2020

Esophageal dysfunction in scleroderma: relationship with disease subsets

1 reference

12 December 2020

Extraoesophageal manifestations of gastro-oesophageal reflux

1 reference

12 December 2020

Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease

1 reference

12 December 2020

Oesophageal manometry in early and definite systemic sclerosis

1 reference

12 December 2020

Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study

1 reference

12 December 2020

Criteria for the classification of early systemic sclerosis.

1 reference

12 December 2020

Antibody-mediated gastrointestinal dysmotility in scleroderma.

1 reference

12 December 2020

Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis

1 reference

12 December 2020

The oral side of Sjögren syndrome. Diagnosis and treatment. A review

1 reference

12 December 2020

Fecal incontinence in scleroderma: assessment of the anal sphincter with thin-section endoanal MR imaging

1 reference

12 December 2020

Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation

1 reference

12 December 2020

Bowel problems in patients with systemic sclerosis

1 reference

12 December 2020

Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.

1 reference

12 December 2020

Severe organ involvement in systemic sclerosis with diffuse scleroderma

1 reference

12 December 2020

Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis

1 reference

12 December 2020

Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH

1 reference

12 December 2020

Antimyenteric neuronal antibodies in scleroderma

1 reference

12 December 2020

Nutritional support in patients with systemic scleroderma

1 reference

12 December 2020

Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases

1 reference

12 December 2020

10.1007/S10620-007-0018-8

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference